Identification of bona fide esophageal adenocarcinoma cell lines.
Shoemaker
Robert H
RH
D000230:Adenocarcinoma / Q000188:drug therapy; D000970:Antineoplastic Agents / Q000494:pharmacology; D001557:Benzenesulfonates / Q000494:pharmacology; D045744:Cell Line, Tumor; D002986:Clinical Trials as Topic / Q000592:standards*; D016172:DNA Fingerprinting; D004938:Esophageal Neoplasms / Q000188:drug therapy; D006801:Humans; D009316:National Institutes of Health (U.S.); D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D011725:Pyridines / Q000494:pharmacology; D000077157:Sorafenib; D020080:Tandem Repeat Sequences; D014481:United States
D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib